Copenhagen, Denmark · Founded 2018 · Privately Held (backing)
Developer of cannabinoids and psilocybin derivatives intended to improve the health and well-being of people. Octarine Bio is based in Copenhagen, Denmark and was founded in 2018. Its last reported valuation was $30.8 million in Jan 2026. It has raised $16.8 million.
Last reported valuation
$30.8M
Oct 2026
Priced at
—
Total raised
$16.8M
Last round
—
Cap table — not yet on record
Octarine Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Octarine Bio with a free account
·The complete investor list: 16 names
·Watch Octarine Bio: the Monday email on marks, rounds and moves
